Atlas Trials

Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation

Clinical trial NCT00431782 · COMPLETED

Trial details

NCT number
NCT00431782
Sponsor
ARYx Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2006-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.